JP2004513059A - ペプチド産物、方法及び組成物 - Google Patents

ペプチド産物、方法及び組成物 Download PDF

Info

Publication number
JP2004513059A
JP2004513059A JP2000590684A JP2000590684A JP2004513059A JP 2004513059 A JP2004513059 A JP 2004513059A JP 2000590684 A JP2000590684 A JP 2000590684A JP 2000590684 A JP2000590684 A JP 2000590684A JP 2004513059 A JP2004513059 A JP 2004513059A
Authority
JP
Japan
Prior art keywords
aceeed
pantp
peptide
represented
peptide product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000590684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513059A5 (cg-RX-API-DMAC10.html
Inventor
ガブビアニ，ジウリオ
スカルソ，アラン
Original Assignee
ユセベ，ソシエテ　アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユセベ，ソシエテ　アノニム filed Critical ユセベ，ソシエテ　アノニム
Publication of JP2004513059A publication Critical patent/JP2004513059A/ja
Publication of JP2004513059A5 publication Critical patent/JP2004513059A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2000590684A 1998-12-24 1999-12-15 ペプチド産物、方法及び組成物 Pending JP2004513059A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204396 1998-12-24
PCT/EP1999/009964 WO2000038733A1 (en) 1998-12-24 1999-12-15 Peptidic product, process and composition

Publications (2)

Publication Number Publication Date
JP2004513059A true JP2004513059A (ja) 2004-04-30
JP2004513059A5 JP2004513059A5 (cg-RX-API-DMAC10.html) 2007-03-15

Family

ID=8234532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590684A Pending JP2004513059A (ja) 1998-12-24 1999-12-15 ペプチド産物、方法及び組成物

Country Status (5)

Country Link
US (1) US6335320B1 (cg-RX-API-DMAC10.html)
EP (1) EP1140202A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004513059A (cg-RX-API-DMAC10.html)
AU (1) AU762006B2 (cg-RX-API-DMAC10.html)
WO (1) WO2000038733A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
WO2005016364A1 (en) * 2003-08-14 2005-02-24 Guthy-Renker Corporation Skin care composition including hexapeptide complexes and methods of their manufacture
RU2255757C1 (ru) * 2004-06-22 2005-07-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Пептидное соединение, восстанавливающее функцию органов дыхания

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07503617A (ja) * 1992-08-21 1995-04-20 バイオジェン，インコーポレイテッド Ｔａｔ由来の輸送ポリペプチド
JPH10510557A (ja) * 1995-10-05 1998-10-13 サントル ナショナル ドゥ ラ ルシェルシェ サイエンティフィック（シーエヌアールエス） 活性分子の細胞内アドレス用ベクターとして利用可能なペプチド
JP2002535247A (ja) * 1998-11-26 2002-10-22 ペンタファルム アクチェンゲゼルシャフト 輸送系複合体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
US5254342A (en) * 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
US5534496A (en) * 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5846743A (en) * 1995-02-22 1998-12-08 Brigham And Women's Hospital, Inc. Polyphoshoinositide binding peptides for intracellular drug delivery
DE69736351T4 (de) * 1996-05-08 2009-07-23 Cyclacel Ltd. Methoden und mittel zur hemmung der cdk4-aktivität
US6551994B1 (en) * 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
EP1005357A1 (en) * 1997-04-14 2000-06-07 The Regents Of The University Of California Peptide antiestrogen compositions and methods for treating breast cancer
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07503617A (ja) * 1992-08-21 1995-04-20 バイオジェン，インコーポレイテッド Ｔａｔ由来の輸送ポリペプチド
JPH10510557A (ja) * 1995-10-05 1998-10-13 サントル ナショナル ドゥ ラ ルシェルシェ サイエンティフィック（シーエヌアールエス） 活性分子の細胞内アドレス用ベクターとして利用可能なペプチド
JP2002535247A (ja) * 1998-11-26 2002-10-22 ペンタファルム アクチェンゲゼルシャフト 輸送系複合体

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6010006211, Ｊ．Ｃｅｌｌ Ｂｉｏｌ．，Ｖｏｌ．１３０，Ｎｏ．４（１９９５）ｐ．８８７−８９５ *
JPN6010006213, Ｂｉｏｃｈｅｍ．Ｂｉｏｐｈｙｓ．Ｒｅｓ．Ｃｏｍｍｕｎ．，Ｖｏｌ．２２９，Ｎｏ．２（１９９６）ｐ．３６３−３６９ *
JPN6010006216, Ｊ．Ｉｍｍｕｎｏｌ．Ｍｅｔｈｏｄｓ，Ｖｏｌ．２１２，Ｎｏ．１（１９９８）ｐ．４１−４８ *
JPN6010006218, Ｊ．Ｂｉｏｌ．Ｃｈｅｍ．，Ｖｏｌ．２６９，Ｎｏ．１４（１９９４）ｐ．１０４４４−１０４５０ *
JPN7010000342, Ｅｘｐｅｒｉｅｎｔｉａ，Ｖｏｌ．５１，Ｎｏ．ＡＢＳＴＲ．（１９９５）ｐ．Ａ６２ *

Also Published As

Publication number Publication date
US6335320B1 (en) 2002-01-01
WO2000038733A1 (en) 2000-07-06
AU762006B2 (en) 2003-06-19
AU2283800A (en) 2000-07-31
EP1140202A1 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
US6825317B2 (en) Cyclic tetrapeptide derivatives and pharmaceutical uses thereof
US6235716B1 (en) Multivalent ligands which modulate angiogenesis
JP4519324B2 (ja) 共有結合で架橋されたインスリンダイマー
US20020035243A1 (en) Transport system conjugates
JP2009024017A (ja) 長期持続性成長ホルモン放出因子誘導体
BG65065B1 (bg) Пептидни антиангиогенни лекарствени средства
NO179505B (no) Fremgangsmåte for fremstilling av en syntetisk ekstracellulær matriks
KR20020010928A (ko) 인테그린 αｖβ６의 억제제로서의 사이클릭 펩타이드유도체
CN118638210A (zh) 长效pth类似物的制备方法及应用
US20100004165A1 (en) Novel Protein Transduction Domains and Uses Therefor
US6683048B1 (en) Compounds and methods for stimulating gene expression and cellular differentiation
US6335320B1 (en) Method of treating fibrotic conditions
JP2003514920A (ja) 抗血管新生活性を有するｎ−アルキル化ペプチド
JP2001514659A (ja) ドラスタチン−１５誘導体とタキサンとの併用
US20210228675A1 (en) Hypertrophic scar inhibiting composition
JP2008505848A (ja) 血管新生阻害剤、それらを含む組成物及び血管新生障害に関連する疾患の治療におけるそれらの使用
CZ20014484A3 (cs) Inhibitory integrinu alfa v beta 6
US7598342B2 (en) Alpha-fetoprotein peptides and uses thereof
US10167326B2 (en) Alpha-fetoprotein “ring and tail” peptides
PL245202B1 (pl) Lipopeptydowe koniugaty i ich sole, sposób wytwarzania lipopeptydowych koniugatów i ich soli, kompozycja farmaceutyczna zawierająca lipopeptydowy koniugat i jego sole do leczenia ran przewlekłych
US7964701B2 (en) Alpha-fetoprotein peptides
JP2025520739A (ja) ペプチド阻害剤およびその使用
JP2002500195A (ja) 自己免疫疾患を治療するためのフィラグリン由来シトルリンペプチドの使用
EP1152011A1 (en) Peptides inhibiting vascular endothelial cell migration
JPH06157588A (ja) 新規な細胞接着活性ペプチド誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061207

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100209

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100629